Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01353950 · ClinicalTrials.gov registry record
Costimulatory Molecules as Biomarkers in Cystic Fibrosis
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 40
- Enrollment target
NCT01353950 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 40 participants.
The verdict
NCT01353950 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the expression of a certain class of molecules, called costimulatory molecules, in humans with Cystic Fibrosis. Cystic Fibrosis is a genetic disorder which renders the lung susceptible to persistent inflammation which, at times, can worsen, resulting in accelerated decline in lung function and eventually death or transplant. Our goal is to determine if the levels of costimulatory markers can be used to predict exacerbation and subsequent lung function decline in subjects with Cystic Fibrosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01353950
The ClinicalTrials.gov registry entry for NCT01353950 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01353950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01353950 about?
NCT01353950 is a clinical study titled "Costimulatory Molecules as Biomarkers in Cystic Fibrosis". The purpose of this study is to investigate the expression of a certain class of molecules, called costimulatory molecules, in humans with Cystic Fibrosis. Cystic Fibrosis is a genetic disorder which renders the lung susceptible to persistent inflammation which, at times, can worsen, resulting in ac...
What is the current status of trial NCT01353950?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2011-07. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01353950?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.